Our joint ambition is to transform research and advance health for patients, customers, and scientific communities. Together we offer clinical trial central and speciality laboratory services. With our enhanced portfolio of integrated services and assay development in multiple therapeutic areas, and the latest technology available in flow cytometry, immunohistochemistry, Next Generation Sequencing, and immunoassays, we offer a comprehensive portfolio of solutions and capabilities at every stage of clinical trials.

Our portfolio of scientific and technical expertise combined with our global capabilities, vast databases of patient data and samples, and best-in-class logistics remove the uncertainty from sample management, reduce risk, and enable the accuracy and acceleration of your drug and vaccine development projects from start to finish.

With our unparalleled scientific expertise, the fast-expanding portfolio of therapeutic areas includes a focus on Oncology and Immuno-Oncology, Metabolic Diseases, Virology and other Infectious Diseases, Inflammatory and Autoimmune Diseases, Neurology and Rare Diseases.

Our joint offering includes:

• Early stage and preclinical testing services, including in-house developed customized animal models.
• Access to biomedical and genetic data from over 45 million patients per year from across Europe, Africa, and North America.
• Capability to sequence 1000-plus whole human genomes per week.
• Unique access to Africa’s growing population including diverse samples for non-clinical research.
• We provide a gateway for customers to conduct studies in China and we are offering local capabilities within an integrated global solution.
• Access to exceptional scientific and technical teams in multiple treatment areas for drug and vaccine development.
• A cutting-edge specialist laboratory network of over 1000 labs including in-house BSL2 and BSL3 labs in Europe, the Americas, Africa, Asia and Australia.
• Largest global PBMC network
• Extended virus biobank services
• Access to specialty techniques including flow cytometry and anatomical pathology solutions.
• Molecular diagnostics expertise, supporting immuno-oncology, cell & gene therapy and infectious diseases clinical trials.

Want to Know More?

We know you might have questions or concerns about this change, and we encourage you to reach out to your dedicated account manager or our customer service team. They will be more than happy to assist you and provide any clarification you may need.

To stay updated on this transition and receive any future communications, we kindly request that you add our new email address @cerbaresearch.com to your contacts list and ensure our emails reach your inbox.

About Cerba Research

Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.

From the translation of preclinical to clinical, through commercialization, our expert scientists collaborate with you to optimize your therapeutic development and obtain critical insights earlier. We help accelerate your therapies through the development of highly specialized custom assays, deep biomarker expertise, and a passion for scientific innovation across complex therapeutic areas.

Our global network of leading, specialty laboratories ensure you have access to quality data and can reach your patients. Together, we’ll improve patients’ lives around the globe.